1995 Genetic Engineering and Our Humanness


  • Ethical and social issues of human germ-line gene manipulation
  • When is it justified?
  • Can it be regulated?
  • What is the public good?

Convened by:
Sheldon Krimsky, Professor of Urban and Environmental Policy, Tufts University; Author, Biotechnics and Society

Adrienne Asch, Henry R. Luce Professor in Biology, Ethics and the Politics of Human Reproduction, Wellesley College
Karl Ebert, Professor, Animal and Cellular Biology, School of Veterinary Medicine, Tufts University
Ruth Hubbard, Professor of Biology Emerita, Harvard University; Author, The Politics of Women’s Biology; Co-Author, Exploding the Gene Myth
Stuart Newman, New York State Medical School
Pilar Ossario, Biologist and Lawyer, University of California/Berkeley
Henri Termeer, Chairman and Chief Executive Officer, Genzyme Corporation
Nelson Wivel, Director, Office of Recombinant DNA Activities, National Institutes of Health